ADVERTISEMENT
Events
Get real time update about this post category directly on your device, subscribe now.
Gene Therapies for Hearing Loss Strike an Encouraging Note in Embattled Modality
Eli Lilly and Regeneron are leading the push to treat congenital deafness with gene therapies, seeking a piece of a...
Validated Mechanisms, Strong Data Beat Hype in Longevity Investing
Longevity is a long-standing buzzword in life sciences, but it now has staying power. The smart trajectory is to stop...
HHS Denies Disbandment of CDC Vaccine Advisory Group in Wake of Court Ruling
A spokesperson for the Department of Health and Human Services refuted the claim, made Thursday on social media by ACIP...
J&J Plans $1B Investment in PA Cell Therapy Manufacturing Facility
Once fully operational, the Pennsylvania site will employ more than 500 people and make cell therapies for thousands of patients...
Trump Takes Drug Pricing Fight To Insurers With ‘The Great Healthcare Plan’
Incoming PhRMA Chair Paul Hudson, a day before the White House announcement, pledged to work with the administration as the...
Dosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)
Paris, France, January 22, 2026 – PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with...
BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer
Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination with Yervoy (ipilimumab), by the...
Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump
WASHINGTON, DC - DECEMBER 19: U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White...
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials
Accure to complete required preclinical studies to file IND application for ACT-02 program in 2026 Fonds National de Recherche (FNR) grant will...
GCE MEDICAL BRINGS FULL GLOBAL SUITE OF GAS CONTROL EQUIPMENT TO ARAB HEALTH MEDICAL EXPO
Zug, Switzerland – GCE Medical, an ESAB Corporation brand, launched the industry’s first full global offering of medical gas control...
CHINA LIFE SCIENCE CONFERENCE 2024 AND CHINA GUANGZHOU INTERNATIONAL LIFE SCIENCE EXPO: Guangzhou, China
CHINA LIFE SCIENCE CONFERENCE 2024 AND CHINA GUANGZHOU INTERNATIONAL LIFE SCIENCE EXPO June 1-3, 2024; Venue: China Import and Export...
Dr. Raymond Liu, Vice-President, Mass General Brigham Global Advisory and Associate Radiologist for the Division of Interventional Radiology at Massachusetts General Hospital
Questions: Could you please tell us a little bit about yourself and your academic background? I currently serve as Vice-President...
Seasonal Affective Disorder’s impact on health & solutions
Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light...
In Search Of Game-Changing Technologies At AUTOMA+ 2023
Game-changing industry trends and technologies were discussed at Healthcare Automation and Digitalisation Congress 2023, that was held in Zurich, Switzerland,...
In Search Of Game-Changing Technologies At AUTOMA+ 2023
Game-changing industry trends and technologies were discussed at Healthcare Automation and Digitalisation Congress 2023, that was held in Zurich, Switzerland,...
Unleash The Full Potential Of AI And Robotics With AUTOMA+ Health 2023
Healthcare Automation and Digitalisation Congress 2023 Machines are getting smarter every day, and companies across the world are discovering new...
Ride The Digital Trasnformation Wave With AUTOMA+ HealthCare 2023
Executive opening panel dedicated to the sustainable digital healthcare ecosystem is the highlight of Healthcare Automation and Digitalization Congress 2023....
